Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:07 AM
Ignite Modification Date:
2025-12-25 @ 2:07 AM
NCT ID:
NCT02920060
Eligibility Criteria:
Inclusion Criteria:
1. Age - 1 year to 16 years
2. Gender - male and female both
3. Refractory generalized convulsive status epilepticus i.e. not responding to any two of the first line drugs
Exclusion Criteria:
1. Patients with epilepsia partialis continua.
2. Patients with definite history of any allergic reaction to intravenous levetiracetam or intravenous valproate, or any contraindications in giving these drugs.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Year
Maximum Age:
16 Years
Study:
NCT02920060
Study Brief:
Protocol Section:
NCT02920060